Literature DB >> 14609333

The crystal structure of AMP-bound PDE4 suggests a mechanism for phosphodiesterase catalysis.

Qing Huai1, John Colicelli, Hengming Ke.   

Abstract

Cyclic nucleotide phosphodiesterases (PDEs) regulate the intracellular concentrations of cyclic 3',5'-adenosine and guanosine monophosphates (cAMP and cGMP, respectively) by hydrolyzing them to AMP and GMP, respectively. Family-selective inhibitors of PDEs have been studied for treatment of various human diseases. However, the catalytic mechanism of cyclic nucleotide hydrolysis by PDEs has remained unclear. We determined the crystal structure of the human PDE4D2 catalytic domain in complex with AMP at 2.4 A resolution. In this structure, two divalent metal ions simultaneously interact with the phosphate group of AMP, implying a binuclear catalysis. In addition, the structure suggested that a hydroxide ion or a water bridging two metal ions may serve as the nucleophile for the hydrolysis of the cAMP phosphodiester bond.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14609333     DOI: 10.1021/bi034653e

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  33 in total

Review 1.  Advances in targeting cyclic nucleotide phosphodiesterases.

Authors:  Donald H Maurice; Hengming Ke; Faiyaz Ahmad; Yousheng Wang; Jay Chung; Vincent C Manganiello
Journal:  Nat Rev Drug Discov       Date:  2014-04       Impact factor: 84.694

Review 2.  The structural basis of arrestin-mediated regulation of G-protein-coupled receptors.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Pharmacol Ther       Date:  2006-02-03       Impact factor: 12.310

3.  Structural basis for the catalytic mechanism of human phosphodiesterase 9.

Authors:  Shenping Liu; Mahmoud N Mansour; Keith S Dillman; Jose R Perez; Dennis E Danley; Paul A Aeed; Samuel P Simons; Peter K Lemotte; Frank S Menniti
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-29       Impact factor: 11.205

4.  Scanning peptide array analyses identify overlapping binding sites for the signalling scaffold proteins, beta-arrestin and RACK1, in cAMP-specific phosphodiesterase PDE4D5.

Authors:  Graeme B Bolger; George S Baillie; Xiang Li; Martin J Lynch; Pawel Herzyk; Ahmed Mohamed; Lisa High Mitchell; Angela McCahill; Christian Hundsrucker; Enno Klussmann; David R Adams; Miles D Houslay
Journal:  Biochem J       Date:  2006-08-15       Impact factor: 3.857

5.  Gene set analysis of purine and pyrimidine antimetabolites cancer therapies.

Authors:  Brooke L Fridley; Anthony Batzler; Liang Li; Fang Li; Alice Matimba; Gregory D Jenkins; Yuan Ji; Liewei Wang; Richard M Weinshilboum
Journal:  Pharmacogenet Genomics       Date:  2011-11       Impact factor: 2.089

6.  Insights into different dependence of dNTP triphosphohydrolase on metal ion species from intracellular ion concentrations in Thermus thermophilus.

Authors:  Naoyuki Kondo; Takashi Nishikubo; Taisuke Wakamatsu; Hirohito Ishikawa; Noriko Nakagawa; Seiki Kuramitsu; Ryoji Masui
Journal:  Extremophiles       Date:  2007-11-08       Impact factor: 2.395

7.  Pharmacophore modeling, 3D-QSAR, and docking study of pyrozolo[1,5-a]pyridine/4,4-dimethylpyrazolone analogues as PDE4 selective inhibitors.

Authors:  Naga Srinivas Tripuraneni; Mohammed Afzal Azam
Journal:  J Mol Model       Date:  2015-10-26       Impact factor: 1.810

8.  Refolding and kinetic characterization of the phosphodiesterase-8A catalytic domain.

Authors:  Zier Yan; Huanchen Wang; Jiwen Cai; Hengming Ke
Journal:  Protein Expr Purif       Date:  2008-10-19       Impact factor: 1.650

9.  Enantiomer discrimination illustrated by the high resolution crystal structures of type 4 phosphodiesterase.

Authors:  Qing Huai; Yingjie Sun; Huanchen Wang; Dwight Macdonald; Renée Aspiotis; Howard Robinson; Zheng Huang; Hengming Ke
Journal:  J Med Chem       Date:  2006-03-23       Impact factor: 7.446

10.  A new insulin-mimetic bis(allixinato)zinc(II) complex: structure-activity relationship of zinc(II) complexes.

Authors:  Yusuke Adachi; Jiro Yoshida; Yukihiro Kodera; Akira Kato; Yutaka Yoshikawa; Yoshitane Kojima; Hiromu Sakurai
Journal:  J Biol Inorg Chem       Date:  2004-09-18       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.